Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Revenue Recognition
Reply New Message
Prev Message Back To Forum Threaded View Next Message

That's how I first read it also - "all revenue was recognized related to all signed license agreements"



However, I think there may still be room for other qualifiers that might defer recognition of revenue.

Was the customer "provided with the licensed technology" as of Q period end? Or, were there other TPL/PTSC agreement obligations that were not yet fulfilled by Q period end?

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply